1.. Introduction {#s0001}
================

Endophytic fungi play an essential part in the physiological and ecological roles \[[@CIT0001]\] including growth promoter, stress tolerance, drought resistance, insect, and herbivores repliers. Antibiotic-producing fungi were the first and continue to be dominating the market \[[@CIT0002]\]. Endophytes are defined as microorganisms that live/colonize within the plant tissues and cause no damage or symptoms of disease. There are regarded as being more beneficial to the plant than detrimental \[[@CIT0003]\]. Current research focuses on using untapped location, medicinal plants and their endophytic fungi to discovery novel, affordable, efficacies pharmaceutical active compounds. This is in the hope of neutralizing the enormous problem of resistance \[[@CIT0004]\].

Despite the knowledge about flora, fauna, and the traditional use of medicinal plant in Southern Africa, South Africa in particular remains an untapped location for host medicinal and aromatic plants with novel microorganisms \[[@CIT0005]\].

The variance of plant to fungal diversity is 1 to 6 \[[@CIT0005]\], increases the probabilities of discovering novel metabolites in the fungal community. From a large number of medicinal plants indigenous to South Africa, *Pelargonium sidoides* DC. have been reported to be the most traditional use plant for primary health care \[[@CIT0006]\]. Due to the aptitude of this plant to produce secondary metabolites, it can be expected that endophytic fungi possessing some antimicrobial properties can be isolated \[[@CIT0007]\].

For decades, bacteria have emerged as important healthcare-associated pathogens. The rapid spread of enterococci with resistance to vancomycin (VRE) has been of particular concern worldwide \[[@CIT0007]\] when a substantial percentage of the population is immune compromised patients \[[@CIT0008]\]. Although, *Enterococcus faecium* is the leading bacteria responsible for medical intensive care units' device-associated infections, other enterococcal species such as *E. avium, E. gallinarum, E. casseliflavus,* are of clinical concerns. Opportunistic diseases in developing countries are a major cause of human mortality due to inadequate sanitation, a lack of safe drinking water, malnourishment, war, and famine claiming approximately 2 million lives a year \[[@CIT0009]\]. While most coliforms are harmless to human health, the presence of *Escherichia coli*, can be accountable for outbreaks of infectious diarrhoea and held responsible for a number of death in developing countries.

Manganyi et al. \[[@CIT0010]\] reported in depth the biodiversity and phylogenetic relationship of the endophytic fungi isolated from *Pelargonium sidoides* DC. The primary objective of the current study was to screen for the antibacterial properties of fungal extracts against seven selected bacteria of clinical interest. And finally to determine the chemical profile of the most abundant bioactive compounds using gas chromatography mass spectrophotometry (GC-MS).

2.. Materials and methods {#s0002}
=========================

2.1. Endophytic fungi isolated from *Pelargonium sidoides* DC {#s0003}
-------------------------------------------------------------

One hundred and thirty three (*n* = 133) endophytic fungi were successfully isolated from healthy leave and roots of *Pelargonium sidoides.* Morphological and molecular identification were performed using internal transcribe spacer (ITS) region as describe by \[[@CIT0010]\]. The pure cultures were preserved in the Agricultural Research Council (ARC, Mycology) on water, slant, and freeze dry for future use.

2.2.. Production of secondary metabolites {#s0004}
-----------------------------------------

The fungal isolates were revived by culturing them on Potato Dextrose agar (PDA, Merck, Darmstadt, Germany) and incubated at 25 °C for 10 days. A plug of active mycelia was inoculated into a 250 mL Erlenmeyer flask containing 50 mL of malt extract broth (MEB; Merck, Darmstadt, Germany). The numbers of spores were counted with a hemocytometer (Merck, Johannesburg, South Africa) and adjusted to 1 × 10^6^ conidia/mL. The secondary metabolites were produced by fermentation as described by Premjanu and Jaynthy \[[@CIT0011]\] and each fermentation performed in triplicate. Briefly, fungal cell mass was removed by filtration through a 0.45 µm syringe filter and the resulting filtrate stored in sterile conical flasks at 4 °C, until further use.

2.3.. Bacteria strains {#s0005}
----------------------

The target bacterial strains used were both environmental strains and control strain (American Type Culture Collection, ATCC; [Table 1](#t0001){ref-type="table"}) with potential clinical implications and are well-known to be resistance against modern antibiotics. Bacteria were cultured in nutrient broth (NB; Merck, Darmstadt, Germany) for 24 h at 37 °C to reach a final suspension of 1 × 10^7^ cells/mL.

###### 

Target bacteria with their origin and accession number.

  Target bacteria             Accession no.   Origin
  --------------------------- --------------- ------------------------------------------
  *Escherichia coli*          ATCC 25922      ATCC collection
  *Escherichia coli*          ID = O177       Environmental isolate from cattle faeces
  *Bacillus cereus*           ATCC 10876      ATCC collection
  *Enterococcus faecalis*     ATCC S1299      Environmental isolate from ground water
  *Enterococcus faecium*      ATCC 700221     Environmental isolate from ground water
  *Enterococcus gallinarum*   ATCC 700425     ATCC collection

ID: Identified as....

2.4.. Antibacterial properties {#s0006}
------------------------------

One hundred and thirty-three (133) extracts were screened for their antibacterial activities against six targeted bacteria strains. The disk diffusion assay was used as described by Ahmad et al. \[[@CIT0012]\] and the experiment done in triplicate. The zone inhibition as the degree of activity was expressed as diameter (mm).

2.5.. Characterization by gas-chromatography mass spectrometry {#s0007}
--------------------------------------------------------------

The most active fungal extracts were selected to undergo secondary metabolites identification using gas-chromatography mass spectrometry GCMS, (GC-MS TQ8050; Shimadzu, Johannesburg, South Africa) equipped with a Multifunctional Autosampler (AOC-6000), a capillary column (RTX-5, 60 m × 0.25 mm × 0.25 µm, New Delhi, India) as described by Sharma et al. \[[@CIT0007]\]. The identities of the compounds were determined by searching known molecules in databases of NIST05; WILEY 8, and FFNSC1.3 libraries.

3.. Results and discussion {#s0008}
==========================

3.1.. Diversity of fungal extracts with antibacterial activity {#s0009}
--------------------------------------------------------------

From all the fungal isolates (*n* = 133) tested; only 16 displayed inhibition activity against the selected bacteria ([Table 2](#t0002){ref-type="table"}). The results ([Figure 1](#F0001){ref-type="fig"}) revealed that approximately 25% were *Penicillium* sp. which was the most dominant genera followed by *Fusarium* sp (19%), *Alternaria* sp. (13%), and *Aspergillus* sp. (7%). These genera belong to the ascomycete's class, which is reported to be one of the two larger class of endophytes \[[@CIT0013]\].The results of *Fusarium* sp. being the second most prevalent genera is not surprising as the *Fusaria* genus is the largest group of filamentous fungi \[[@CIT0014]\]. *Geotrichum* sp. which falls under the same division (Ascomycota) as fungi, has been isolated from clones cocoa resistant VSD M.05 \[[@CIT0015]\] and has been associated with the growth promoting protection capabilities of the plant hosts from pests and diseases.

![Diversity of fungal extracts displaying antibacterial activity.](TMYB_A_1631121_F0001_C){#F0001}

###### 

Antimicrobial activity of extracts produced by endophytic fungal isolated from *Pelargonium sidoides*.

  Sample. No   Sample ID   Probable ID     Zone of inhibition (mm)                                                        
  ------------ ----------- --------------- ----------------------------- --------- --------- -------- --------- --------- ---------
  1            RNK 001     *Talaromyces*   sp.                           \+ (9)    --        --       --        \+ (6)    --
  2            RNK 004     *Penicillium*   *glabrum*                     ++ (11)   --        --       --        --        --
  3            RNK 016     *Alternaria*    *tenuissima*                  --        --        \+ (9)   --        --        --
  4            PG 9        *Chaetomium*    *subaffine*                   --        \+ (9)    \+ (6)   --        --        --
  5            PG 10       *Humicola*      sp.                           --        --        \+ (6)   --        --        --
  6            END 015     *Boeremia*      *exigua var. pseudolilacis*   --        --        --       ++ (11)   --        --
  7            END 017,1   *Penicillium*   sp.                           \+ (9)    --        --       --        --        --
  8            END 021     *Penicillium*   *commune*                     \+ (10)   --        --       --        --        --
  9            MHE 001     *Fusarium*      *solani*                      --        ++ (11)   --       --        --        --
  10           MHE 010     *Neurospora*    *crassa*                      \+ (9)    \+ (8)    --       --        --        --
  11           MHE 011     *Penicillium*   sp.                           \+ (9)    --        --       --        --        --
  12           MHE 033     *Aspergillus*   sp.                           \+ (2)    \+ (9)    --       --        --        --
  13           MHE 055     *Fusarium*      *solani*                      --        ++ (12)   --       --        --        --
  14           MHE 056     *Fusarium*      sp.                           --        --        \+ (8)   --        ++ (11)   --
  15           MHE 059     *Geotrichum*    *candidum*                    \+ (9)    --        --       --        --        --
  16           MHE 068     *Alternaria*    sp.                           --        --        \+ (8)   --        ++ (11)   ++ (12)

3.2.. Antibacterial activity against selected bacteria {#s0010}
------------------------------------------------------

Furthermore, the results showed that most endophytic fungal extracts from medicinal plants have limited antibacterial activity. None of the isolates tested were able to control all six pathogenic bacteria. Only MHE 068 isolate, identified as *Alternaria* sp. ([Figure 2](#F0002){ref-type="fig"}) displayed signaficant antibacterial activity against three bacterial strains (*B. cereus*, *E. faecium* (ATCC 700221) and *E. gallinarum*). These findings are supported by \[[@CIT0002]\], who reported similar results about *Alternaria* sp. exhibiting antibacterial activities against *Bacillus* sp., *Staphylococcus aureus, E. faecalis*, and *E. coli*. Despite of the overall 25% activity of *Penicillium* genera, the results show that *Penicillium* sp. could only inhibit *E. coli* (ATCC 25922) and nothing else. The discovery of antibiotics started with *Penicillium* strain producing bioactive compounds with significant biological properties which revolutionized medicine and pharmaceutical products. The *Penicillium* extracts in this study exhibited narrow spectrum of activity.

![Endophytic fungi *Alternaria* (a) Conidia structure wrapped in mycelia (b) individual conidia structure (scale bars: 100 µm).](TMYB_A_1631121_F0002_B){#F0002}

In addition, it can be noted that the three *Fusarium* isolates displaying some antibacterial activities against *B. cereus*, *E. coil* (ATCC 0177), and *E. faecium* (ATCC 700221). As reported by \[[@CIT0016]\], the endophytic *Fusarium* sp. is primarily known to exhibit good antibacterial activities against *E. coli*.

3.3.. Characterization of bioactive compounds by GC-MS analysis {#s0011}
---------------------------------------------------------------

As previously stated, only the most effective extract (MHE 68, *Alternaria* sp.) was further analysed by GC-MS. Out of twenty compounds, separated and preliminary identified, the fatty acid, 9,12-octadecadienoic acid (Z,Z) (34%) commonly known as linoleic acid, was detected as dominant compound followed by several peaks initially identified as a cyclic volatile, eicosamethyl-cyclodecasiloxane oligomers ([Table 3](#t0003){ref-type="table"}). Like several endophytic fungi, *Alternaria* sp. has been reported to exhibit significant level antibacterial activity against Gram positive and negative bacteria \[[@CIT0017]\]. The antibacterial activity can be attributed to the high level of linoleic acid which has been reported to inhibit the binding of *E. coli* heat-labile enterotoxin (LT) to the receptor ganglioside GM1 in rabbit \[[@CIT0018]\].

###### 

Main compounds identified in fungal extracts (Sample MHE 68).

       Name                                                                         Retention Time (min)   Height   Area
  ---- ---------------------------------------------------------------------------- ---------------------- -------- ---------
  1    Tetradecamethyl hexasiloxane                                                 21.9                   49846    107935
  2    Tetradecamethyl hexasiloxane                                                 24.1                   70746    134156
  3    Group of octadecadienoic acid                                                25.9                   84122    146379
  4    Group of octadecadienoic acid                                                26.6                   178016   271510
  5    Group of octadecadienoic acid                                                26.7                   304562   593966
  6    Group of octadecadienoic acid                                                26.7                   172773   340337
  7    Group of octadecadienoic acid                                                26.9                   96415    287016
  8    Group of octadecadienoic acid                                                27.1                   779997   1597988
  9    Eicosamethyl cyclodecasiloxane                                               27.2                   114397   250984
  10   1H-Purin-6-amine, N-((3-fluorophenyl)methyl)-6-(3-fluorobenzylamino)purine   27.6                   22586    68648
  11   Eicosamethyl cyclodecasiloxane                                               28.4                   108477   292869
  12   Tetradecamethyl hexasiloxane                                                 29.6                   99113    272854
  13   1H-Purin-6-amine, N-((3-fluorophenyl)methyl)-6-(3-fluorobenzylamino)purine   29.9                   13195    78786
  14   Eicosamethyl cyclodecasiloxane                                               30.6                   102788   244851
  15   1H-Purin-6-amine, N-((3-fluorophenyl)methyl)-6-(3-fluorobenzylamino)purine   30.8                   23772    61412
  16   Eicosamethyl cyclodecasiloxane                                               31.6                   50978    107960
  17   Propanoic acid                                                               32.6                   26327    64355
  18   Methyl 2,3,4-tri-O-acetyl-6-deoxy-6-iodo-α-D-glucopyranoside                 33.2                   19795    84775
  19   1,2-Benzenediol                                                              33.7                   25879    94106
  20   6-Decylsulfonylhexane-1,2,3,4,5-pentol                                       34.6                   25345    107673

Furthermore, the antibacterial activity of plant volatile oils including cyclic volatiles have been demonstrated its activity against 25 different genera of bacteria such as *E. coli* and *E. faecalis* (NCTC 775) \[[@CIT0019]\]. In conclusion, the study confirmed the potential use of endophytes from untapped indigenous medicinal plant for the control of opportunistic pathogens responsible for the mortality rate in developing countries. The extract from the *Alternaria* strain clearly confirmed the presence of linoleic acid. However, further studies on the optimization of the fermentation process and purification of the compounds are needed. As well as further bio-guided fractionation by nuclear magnetic resonance (NMR) and MS spectroscopy is necessary in future studies. This does not omit that the data obtained is critical in the investigation of novel bioactive compounds against bacterial strains of clinical importance. This is the first report on endophytic fungi isolated from *Pelargonium sidoides* DC. which were screened for their antibacterial activities.
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